Indegene Limited — JV/Acquisition, 17-10-2025: Acquisition

Indegene's subsidiary will acquire 100% equity in UK-based Warn and Co Limited for a total consideration not exceeding GBP 3 million in an all-cash deal. Warn, which reported revenues of GBP 2.5 million in its last financial year, specializes in business transformation consulting for Life Sciences companies. This acquisition strategically bolsters Indegene's capabilities and service offerings in the life sciences consulting business, particularly strengthening its footprint and specialized expertise in the UK market. This move enhances Indegene's competitive edge.